Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.110
+0.050 (4.72%)
Dec 20, 2024, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -57.83 | -73.35 | 5.34 | -50.87 | -17.71 | -20.73 |
| Depreciation & Amortization | 2.61 | 2.23 | 1.12 | 0.4 | 0.21 | 0.35 |
| Other Amortization | 3.2 | 3.2 | 3.2 | 0.2 | - | - |
| Loss (Gain) From Sale of Assets | - | - | -0.35 | - | - | -0 |
| Stock-Based Compensation | 4.74 | 5.06 | 9.88 | 16.49 | 3.63 | 0.83 |
| Other Operating Activities | 9.08 | 5.77 | -28.1 | 8.37 | 0.92 | -1.97 |
| Change in Accounts Receivable | -14.97 | 5.8 | -5.83 | 0.56 | 0.48 | -0.96 |
| Change in Accounts Payable | -2.44 | -3.38 | 1.14 | -3.53 | 0.59 | 2.97 |
| Change in Unearned Revenue | 2.04 | - | -0.18 | -0.06 | -0.03 | 0.21 |
| Change in Other Net Operating Assets | -8.07 | 3.75 | -0.65 | -4.15 | 0.89 | 0.71 |
| Operating Cash Flow | -61.63 | -50.93 | -14.43 | -32.58 | -11.03 | -18.68 |
| Capital Expenditures | -0.46 | -5.41 | -6.14 | -1.15 | -0.29 | -0.13 |
| Sale of Property, Plant & Equipment | - | - | 0.39 | - | - | 0 |
| Cash Acquisitions | - | - | - | -11.77 | - | - |
| Investing Cash Flow | -0.46 | -5.41 | -5.75 | -12.91 | -0.29 | -0.12 |
| Long-Term Debt Issued | - | - | - | - | 41.24 | - |
| Short-Term Debt Repaid | - | - | -0.16 | - | - | - |
| Total Debt Repaid | - | - | -0.16 | - | - | - |
| Net Debt Issued (Repaid) | - | - | -0.16 | - | 41.24 | - |
| Issuance of Common Stock | 1.44 | 2.04 | 0.48 | 102.77 | - | 0 |
| Other Financing Activities | - | -0.16 | - | -5.27 | 0.19 | 2.04 |
| Financing Cash Flow | 1.44 | 1.87 | 0.33 | 222.74 | 41.44 | 2.04 |
| Foreign Exchange Rate Adjustments | 6.45 | 2.17 | 0.19 | -6.46 | 1.72 | -0.44 |
| Net Cash Flow | -54.21 | -52.3 | -19.67 | 170.79 | 31.83 | -17.21 |
| Free Cash Flow | -62.09 | -56.34 | -20.57 | -33.73 | -11.32 | -18.81 |
| Free Cash Flow Margin | -414.79% | -7024.69% | -46.01% | -12585.45% | -234.83% | -274.80% |
| Free Cash Flow Per Share | -1.59 | -1.47 | -0.54 | -1.30 | -1.43 | -801.48 |
| Cash Interest Paid | - | - | - | 1.84 | 0 | - |
| Cash Income Tax Paid | - | - | - | 0.15 | - | - |
| Levered Free Cash Flow | -50.75 | -42.35 | 1.64 | -16.54 | -7.14 | - |
| Unlevered Free Cash Flow | -50.72 | -42.33 | 1.65 | -14.87 | -4.89 | - |
| Change in Net Working Capital | 21.78 | -2.85 | 4.61 | 5.05 | -2.05 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.